Detail of the session
Type :
PLENARY SESSION 2
PLENARY SESSION 2
Date :
Friday 26th April 2019
Friday 26th April 2019
Schedule :
10h30 - 12h30
10h30 - 12h30
Session Title :
PS02 - Plenary Session 2: Novelties in Therapeutics
O027
10h30 - 10h48
10h30 - 10h48
Anti TNF and small molecules in psoriasis
Sandra PHILIPP - Germany
Sandra PHILIPP - Germany
O028
10h48 - 11h06
10h48 - 11h06
Anti IL17 in psoriasis
Carle PAUL - France
Carle PAUL - France
O029
11h06 - 11h24
11h06 - 11h24
Anti p40/anti p19 in psoriasis
Kristian REICH - Germany
Kristian REICH - Germany
O030
11h24 - 11h42
11h24 - 11h42
New molecules in atopic dermatitis
Diamant THAÇI - Germany
Diamant THAÇI - Germany
O031
11h42 - 12h00
11h42 - 12h00
Which drug for which patient ?
Emilie SBIDIAN - France
Emilie SBIDIAN - France
O032A
12h00 - 12h18
12h00 - 12h18
Latest trials on the effect of biotherapy on cardiovascular disease in psoriasis
Nehal MEHTA - United States
Nehal MEHTA - United States